208 related articles for article (PubMed ID: 22674574)
1. Transforming growth factor-β/SMAD Target gene SKIL is negatively regulated by the transcriptional cofactor complex SNON-SMAD4.
Tecalco-Cruz AC; Sosa-Garrocho M; Vázquez-Victorio G; Ortiz-García L; Domínguez-Hüttinger E; Macías-Silva M
J Biol Chem; 2012 Aug; 287(32):26764-76. PubMed ID: 22674574
[TBL] [Abstract][Full Text] [Related]
2. Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation.
Levy L; Howell M; Das D; Harkin S; Episkopou V; Hill CS
Mol Cell Biol; 2007 Sep; 27(17):6068-83. PubMed ID: 17591695
[TBL] [Abstract][Full Text] [Related]
3. Requirement for the SnoN oncoprotein in transforming growth factor beta-induced oncogenic transformation of fibroblast cells.
Zhu Q; Pearson-White S; Luo K
Mol Cell Biol; 2005 Dec; 25(24):10731-44. PubMed ID: 16314499
[TBL] [Abstract][Full Text] [Related]
4. SnoN co-repressor binds and represses smad7 gene promoter.
Briones-Orta MA; Sosa-Garrocho M; Moreno-Alvarez P; Fonseca-Sánchez MA; Macías-Silva M
Biochem Biophys Res Commun; 2006 Mar; 341(3):889-94. PubMed ID: 16442497
[TBL] [Abstract][Full Text] [Related]
5. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins.
He J; Tegen SB; Krawitz AR; Martin GS; Luo K
J Biol Chem; 2003 Aug; 278(33):30540-7. PubMed ID: 12764135
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic SnoN in normal tissues and nonmalignant cells antagonizes TGF-beta signaling by sequestration of the Smad proteins.
Krakowski AR; Laboureau J; Mauviel A; Bissell MJ; Luo K
Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12437-42. PubMed ID: 16109768
[TBL] [Abstract][Full Text] [Related]
7. Up-regulated transcriptional repressors SnoN and Ski bind Smad proteins to antagonize transforming growth factor-beta signals during liver regeneration.
Macias-Silva M; Li W; Leu JI; Crissey MA; Taub R
J Biol Chem; 2002 Aug; 277(32):28483-90. PubMed ID: 12023281
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Ubiquitylome Analysis Reveals the Specificity of RNF111/Arkadia E3 Ubiquitin Ligase for its Degradative Substrates SKI and SKIL/SnoN in TGF-β Signaling Pathway.
Laigle V; Dingli F; Amhaz S; Perron T; Chouchène M; Colasse S; Petit I; Poullet P; Loew D; Prunier C; Levy L
Mol Cell Proteomics; 2021; 20():100173. PubMed ID: 34740826
[TBL] [Abstract][Full Text] [Related]
9. Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein.
Stroschein SL; Wang W; Zhou S; Zhou Q; Luo K
Science; 1999 Oct; 286(5440):771-4. PubMed ID: 10531062
[TBL] [Abstract][Full Text] [Related]
10. SnoN oncoprotein enhances estrogen receptor-α transcriptional activity.
Band AM; Laiho M
Cell Signal; 2012 Apr; 24(4):922-30. PubMed ID: 22227247
[TBL] [Abstract][Full Text] [Related]
11. SnoN Stabilizes the SMAD3/SMAD4 Protein Complex.
Walldén K; Nyman T; Hällberg BM
Sci Rep; 2017 Apr; 7():46370. PubMed ID: 28397834
[TBL] [Abstract][Full Text] [Related]
12. Arkadia induces degradation of SnoN and c-Ski to enhance transforming growth factor-beta signaling.
Nagano Y; Mavrakis KJ; Lee KL; Fujii T; Koinuma D; Sase H; Yuki K; Isogaya K; Saitoh M; Imamura T; Episkopou V; Miyazono K; Miyazawa K
J Biol Chem; 2007 Jul; 282(28):20492-501. PubMed ID: 17510063
[TBL] [Abstract][Full Text] [Related]
13. Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling.
Baldwin RL; Tran H; Karlan BY
Cancer Res; 2003 Mar; 63(6):1413-9. PubMed ID: 12649207
[TBL] [Abstract][Full Text] [Related]
14. Are Ski and SnoN Involved in the Tumorigenesis of Oral Squamous Cell Carcinoma Through Smad4?
Alaeddini M; Etemad-Moghadam S
Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):626-630. PubMed ID: 29734252
[TBL] [Abstract][Full Text] [Related]
15. The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways.
Lei S; Dubeykovskiy A; Chakladar A; Wojtukiewicz L; Wang TC
J Biol Chem; 2004 Oct; 279(41):42492-502. PubMed ID: 15292219
[TBL] [Abstract][Full Text] [Related]
16. Efficient TGF-β/SMAD signaling in human melanoma cells associated with high c-SKI/SnoN expression.
Javelaud D; van Kempen L; Alexaki VI; Le Scolan E; Luo K; Mauviel A
Mol Cancer; 2011 Jan; 10(1):2. PubMed ID: 21211030
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis for the cell type specific induction of SnoN expression by hepatocyte growth factor.
Tan R; Zhang X; Yang J; Li Y; Liu Y
J Am Soc Nephrol; 2007 Aug; 18(8):2340-9. PubMed ID: 17625116
[TBL] [Abstract][Full Text] [Related]
18. SnoN is a cell type-specific mediator of transforming growth factor-beta responses.
Sarker KP; Wilson SM; Bonni S
J Biol Chem; 2005 Apr; 280(13):13037-46. PubMed ID: 15677458
[TBL] [Abstract][Full Text] [Related]
19. SKIL/SnoN attenuates TGF-β1/SMAD signaling-dependent collagen synthesis in hepatic fibrosis.
Chi C; Liang X; Cui T; Gao X; Liu R; Yin C
Biomol Biomed; 2023 Nov; 23(6):1014-1025. PubMed ID: 37389959
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein-7 inhibits proximal tubular epithelial cell Smad3 signaling via increased SnoN expression.
Luo DD; Phillips A; Fraser D
Am J Pathol; 2010 Mar; 176(3):1139-47. PubMed ID: 20093492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]